Navigation Links
Sangamo BioSciences Announces Presentation of Positive Clinical Data From Novel ZFN Therapeutic Approach for the Treatment of HIV/AIDs at Conference for Retroviral and Opportunistic Infections
Date:2/28/2011

fied cells behave like unmodified cells and traffic to the gut mucosa. In addition, we observed selective expansion of ZFN-modified cells in the gut mucosa, a major reservoir of HIV in the body, suggesting that these cells are protected from HIV and selectively enrich in the presence of the virus. These data are consistent with our preclinical findings†. The data also underscore our decision to expand our clinical studies to populations of HIV-infected individuals that have active viral replication and thus higher viral loads and retain immune reactivity to HIV.  From such studies we will be able to assess the effect of ZFN-CCR5-modified T- cells on overall T-cell numbers and the course of the viral infection."

"This presentation is a terrific beginning to a transformational year of clinical data for Sangamo," stated Edward Lanphier, Sangamo's president and chief executive officer. "Later in 2011, we expect to present additional clinical data from our ZFP Therapeutic® programs in HIV/AIDs as well as data from our Phase 2b clinical trial (SB-509-901) of a first-in-class, disease modifying-approach to diabetic neuropathy. The data presented at CROI are the latest example of our substantial progress towards our goal of establishing ZFP Therapeutics as a new and highly differentiated class of human pharmaceuticals to address unmet medical needs."

† (Nat Biotechnol. 2008 Jul;26(7):808-16  Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases).

About the SB-728-T Clinical Trial (SB-728-902)

The study is an open-label Phase 1 clinical trial to evaluate the safety and tolerability of single infusions of an escalating dose of an autologous (a patient's own) CD4+ T-cell product genetically modified at the CCR5 gene by CCR5-specific ZFNs (SB-728-T). The trial will enroll a total of nine HIV-infected subjects (three cohorts of three subjects each) who have sub-optimal
'/>"/>

SOURCE Sangamo BioSciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Sangamo BioSciences and Sigma-Aldrich Announce Nature Biotechnology Study Demonstrating Zinc Finger Technology for Modification of Human Stem Cells
2. Sangamo BioSciences Announces Completion of Enrollment of Phase 2 Clinical Trial of ZFP Therapeutic for Diabetic Neuropathy
3. Sangamo BioSciences Reports 2007 Fourth Quarter and Year-End Financial Results
4. Sangamo BioSciences and Sigma-Aldrich Announce Publication of Study Demonstrating Zinc Finger Technology for Rapid Generation of Knock-Out Cell Lines
5. Sangamo BioSciences Announces Presentation of Data on ZFP Therapeutic for Glioblastoma at American Association for Cancer Research (AACR) Meeting
6. Sangamo BioSciences Provides Update on Diabetic Neuropathy Clinical Programs
7. Sangamo BioSciences Announces Presentation of Phase 1b ZFP Therapeutic Data at American Diabetes Association Meeting
8. Sangamo BioSciences Announces Nature Biotechnology Study Demonstrating the Use of Zinc Finger Nucleases to Generate HIV Resistant T Cells
9. Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS)
10. Sangamo BioSciences Provides Update on Companys 2008 Progress and 2009 Objectives
11. Sangamo BioSciences Announces Presentations at Two Upcoming Investor Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... Research and Markets ( http://www.researchandmarkets.com/research/cng4gn/refurbished ) has announced the ... Global Forecasts to 2019" report to their offering. ... estimated to grow expected to reach $9.37 billion by ... 2019. Factors such as growing ... increasing privatization in the healthcare sector, and rising adoption ...
(Date:7/28/2015)... , July 28, 2015  Nevro Corp. ... company that is providing innovative evidence-based solutions for ... publication of the SENZA-RCT results in the Online ... of the American Society of Anesthesiologists. ... study that was the first to directly compare ...
(Date:7/28/2015)... 28, 2015 A German Diabetes Center clinical ... reuteri probiotic enriches human gut microbiota and modifies ... The study involved daily administration of Nutraceutix,s L. ... the patented BIO- tract ® delivery technology ... on their way to the intestinal tract. ...
Breaking Medicine Technology:Refurbished Medical Equipment Market 2015 - Global Forecasts to 2019 2Nevro Announces Publication of SENZA-RCT Results in Anesthesiology 2Nutraceutix's L. reuteri Probiotic Clinically Proven to Modulate Gut Insulin Metabolism 2
(Date:7/28/2015)... ... July 28, 2015 , ... World Patent Marketing, a vertically ... that cleans pools efficiently - minus the backbreaking work. , "The Swimming Pool ... Director of World Patent Marketing. "It is a sleeping giant that has woken ...
(Date:7/28/2015)... ... 2015 , ... The Triumph Modular, Redefining Modular™ site offers ... library, floor plans, educational blog and wide use of imagery. The Design Build ... valuable links to useful reports by industry experts. Comments are welcomed and encouraged. ...
(Date:7/28/2015)... ... ... Mindful Her, a unique women’s wellness and lifestyle event designed to inspire ... to the next level, announced today an influential line-up of inspiring speakers, including Mallika ... Girls, an Orange County based non-profit that works locally and globally to help girls ...
(Date:7/28/2015)... ... July 28, 2015 , ... World Patent Marketing, ... new household invention that makes shelling eggs an exact science. , “The global ... Cooper, CEO and Creative Director of World Patent Marketing. “With a growth rate ...
(Date:7/28/2015)... FL (PRWEB) , ... July 28, 2015 , ... ... and The Miriam Hospital examines outcomes for inmates who continued methadone maintenance treatment ... latter group was more likely to relapse to opiate use (1) and more ...
Breaking Medicine News(10 mins):Health News:10 Fascinating Things You Never Knew About Swimming Pools Is Introduced by World Patent Marketing and Skimmer Helper 2Health News:10 Fascinating Things You Never Knew About Swimming Pools Is Introduced by World Patent Marketing and Skimmer Helper 3Health News:10 Fascinating Things You Never Knew About Swimming Pools Is Introduced by World Patent Marketing and Skimmer Helper 4Health News:10 Fascinating Things You Never Knew About Swimming Pools Is Introduced by World Patent Marketing and Skimmer Helper 5Health News:Triumph Modular Launches Refreshed Modular Building Industry Website 2Health News:Women’s Healthy Living Event Mindful Her Set for October 24, 2015 in Orange County 2Health News:Women’s Healthy Living Event Mindful Her Set for October 24, 2015 in Orange County 3Health News:Essential Bang For Your Buck Kitchen Items Presented By World Patent Marketing 2Health News:Essential Bang For Your Buck Kitchen Items Presented By World Patent Marketing 3Health News:Essential Bang For Your Buck Kitchen Items Presented By World Patent Marketing 4Health News:Essential Bang For Your Buck Kitchen Items Presented By World Patent Marketing 5Health News:Novus Medical Detox Center Analyzes Methadone Study Findings and Implications for Opiate Abuse Treatment 2Health News:Novus Medical Detox Center Analyzes Methadone Study Findings and Implications for Opiate Abuse Treatment 3Health News:Novus Medical Detox Center Analyzes Methadone Study Findings and Implications for Opiate Abuse Treatment 4
... technology in India is very similar to the technology in ... States turning// towards India for filling up nursing vacancies. With ... imparted, nurses from India are realizing their dream of seeking ... infact recruited eight nurses from India who will be joining ...
... fresh bid to end the anti-reservation medicos strike in India, ... demand for an experts committee on quota in central educational ... decided to intensify the agitation by calling a bandh in ... hectic negotiations, the medicos held talks with Federal Minister Oscar ...
... for conducting global clinical trials due to availability of ... professionals and sophisticated technological infrastructure. // ,The ... Rs 3.1 billion in 2005 and is expected to ... the US and European nations are outsourcing clinical trials ...
... the US have created an artificial penis that has ... one day help treat men with severe erectile dysfunction.// ... colleagues at the Wake Forest Institute for Regenerative Medicine ... of tissue engineering, reported the online edition of New ...
... the Pakistani city of Faisalabad have been affected by contaminated ... number of victims of water-borne diseases, which broke out as ... Abad, seems to further increase as more people are being ... in the affected area is also underway. , ,'we ...
... seems not to have affected the resolve of the students ... a worse turn when two frustrated students tried to self ... Orissa. , ,Rishi Ranjan, 23, whom the police described ... Lila ground where medicos, who had gathered in strength, staged ...
Cached Medicine News:Health News:Two Students Try To Self-Immolate As Anti-Quota Stir Continues 2Health News:Two Students Try To Self-Immolate As Anti-Quota Stir Continues 3
Karlin Crank Frame Spinal Retractor Set is designed for posterior lumbar and thoracic spine surgery. Arm design allows the blades be pre-positioned in the wound prior to attachment....
The Boss Image-Trac system provides superior exposure for all surgical procedures from T1 to S1....
The Unitrac Retraction System is a pneumatic device that provides absolute rigid retraction and stable positioning to the operating room, freeing the surgical assistant to carry out higher priority t...
... Graft represents an rhBMP-2 (recombinant human bone ... bovine-derived absorbable collagen sponge (ACS) carrier. The ... is indicated for spinal fusion procedures in ... (DDD) at one level from L4-S1, who ...
Medicine Products: